Post-diagnosis peripheral adipokine concentrations of leptin, adiponectin and resistin were not associated with all-cause mortality, BCM or recurrence in ERPR positive breast cancer cases, contributing to the emerging evidence that there may be little prognostic value of circulating adipokines. This evidence concerns the gene LEP and breast cancer.